HSP90 inhibitor-induced MCL1 downregulation correlated with sensitivity in a panel of nine mesothelioma and seven lung adenocarcinoma cell lines (Figure 3a, Supplementary Figure S4A). Here, MCL1 is linked to mesothelioma.